All lobbying filings
FRONTLINE GOVERNMENT RELATIONS
Lobbying for EMPOWER PHARMACY · Compounding pharmacy
Filing
3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$45,000.00
What the client paid this registrant for the period.
Client based in
Texas
Government bodies contacted
3
Lobbying activity
2
Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.
Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.